| Titre : | Risk of brain tumors associated with exposure to exogenous female sex hormones. (2006) |
| Auteurs : | Annette WIGERTZ ; Anders AHLBOM ; Maria FEYCHTING ; HALL (Per) : SWE. Department of Medical Epidemiology and Biostatistics. Karolinska Institute. Stockholm. ; Stefan LONN ; MATHIESEN (Tiit) : SWE. Department of Clinical Neuroscience. Karolinska University Hospital. Stockholm. ; Karolinska Institute. Institute of Environmental Medicine. Stockholm. SWE |
| Type de document : | Article |
| Dans : | American journal of epidemiology (vol. 164, n° 7, 2006) |
| Pagination : | 629-636 |
| Langues: | Anglais |
| Mots-clés : | Facteur risque ; Suède ; Europe ; Facteur associé ; Association ; Exposition ; Femme ; Enquête cas témoin ; Epidémiologie ; Contraceptif oral ; Contraceptif ; Voie orale ; Ménopause ; Produit substitution ; Homme ; Système nerveux [pathologie] ; Tumeur bénigne |
| Résumé : | [BDSP. Notice produite par INIST-CNRS R0xdaPOJ. Diffusion soumise à autorisation]. The etiology of brain tumors is largely unknown. Prior observations have implicated gender-specific hormones in the pathogenesis of these tumors. In a population-based case-control study, the authors identified all women aged 20-69 years who had been diagnosed with meningioma or glioma during 2000-2002 in four regions of Sweden. Controls were randomly selected from the study base. Detailed information on hormone usage, including use of hormonal contraceptives, hormonal treatment for gynecologic problems, and hormone replacement therapy, was collected from 178 meningioma cases, 115 glioma cases, and 323 controls. Data were analyzed using unconditional logistic regression, adjusting for age, residential area, education, and parity. An increased relative risk of meningioma was found among postmenopausal women for ever use of hormone replacement therapy, with an odds ratio of 1.7 (95% confidence interval : 1.0,2.8). Women who had used long-acting hormonal contraceptives (subdermal implants, injections, or hormonal intrauterine devices) had an increased risk of meningioma ; the odds ratio for at least 10 years of use was 2.7 (95% confidence interval : 0.9,7.5). Hormone usage was not associated with glioma risk in this study. The findings suggest that the use of female sex steroids may increase the risk of meningioma. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact